The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (72)
The Hallmarks of Cancer
2000 • 27,569 citations
STATs and Gene Regulation
1997 • 3,927 citations
The Bcl2 family: regulators of the cellular life-or-death switch
2002 • 3,782 citations
STATs: transcriptional control and biological impact
2002 • 3,050 citations
Stat3 as an Oncogene
1999 • 2,770 citations
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 • 2,410 citations
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 • 2,394 citations
STATs in oncogenesis
2000 • 1,723 citations
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 • 1,655 citations
Arginine-rich Peptides
2001 • 1,582 citations
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
2000 • 1,549 citations
Mechanisms of Apoptosis
2000 • 1,249 citations
The role of STATs in transcriptional control and their impact on cellular function
2000 • 1,186 citations
Transcription factors as targets for cancer therapy
2002 • 1,147 citations
Bcl-2 family proteins
1998 • 1,055 citations
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
2002 • 1,027 citations
Cellular stress response and apoptosis in cancer therapy
2001 • 793 citations
Three-dimensional structure of the Stat3β homodimer bound to DNA
1998 • 769 citations
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
2001 • 751 citations
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
2002 • 739 citations
Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
2003 • 704 citations
Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis
1996 • 661 citations
Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells
1987 • 657 citations
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
2000 • 625 citations
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
2001 • 617 citations
Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
2003 • 562 citations
The role of proteases during apoptosis
1996 • 558 citations
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
2001 • 546 citations
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
2003 • 540 citations
Issues and progress with protein kinase inhibitors for cancer treatment
2003 • 529 citations
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.
1998 • 508 citations
In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA
2000 • 456 citations
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
2001 • 445 citations
Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
1996 • 444 citations
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
2001 • 436 citations
In VivoDelivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis
2002 • 418 citations
Chemotherapy: targeting the mitochondrial cell death pathway
2002 • 396 citations
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
1997 • 370 citations
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
2002 • 367 citations
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
1999 • 315 citations
Cooperation between STAT3 and c-Jun Suppresses Fas Transcription
2001 • 248 citations
A proapoptotic peptide for the treatment of solid tumors.
2001 • 245 citations
c-Src, Receptor Tyrosine Kinases, and Human Cancer
1999 • 244 citations
Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein
2000 • 238 citations
Tyrosine kinases as targets in cancer therapy – successes and failures
2003 • 223 citations
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
1995 • 220 citations
Death receptors and melanoma resistance to apoptosis
2003 • 210 citations
Protection against ischemic brain injury by protein therapeutics
2002 • 196 citations
Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6
1997 • 146 citations
Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides
2002 • 133 citations
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest.
2001 • 127 citations
Identification of a High-Affinity Phosphopeptide Inhibitor of Stat3
2003 • 127 citations
Constrained peptides as binding entities
1995 • 121 citations
An artificial cell-cycle inhibitor isolated from a combinatorial library
1998 • 111 citations
Tyrosine kinases as targets for cancer therapy
2002 • 101 citations
Induction of apoptosis in lung-cancer cells followingbcl-xL anti-sense treatment
2000 • 96 citations
Sequence-specific Peptide Aptamers, Interacting with the Intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells
2003 • 88 citations
Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity
2001 • 84 citations
Targeting cyclin-dependent kinases in Drosophila with peptide aptamers
1998 • 84 citations
Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity
1999 • 84 citations
Selective Inhibition of Growth Factor-stimulated Mitogenesis by a Cell-permeable Grb2-binding Peptide
1997 • 74 citations
Protein Therapy: In Vivo Protein Transduction by Polyarginine (11R) PTD and Subcellular Targeting Delivery
2003 • 73 citations
Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1
1997 • 70 citations
bcl-xl antisense treatment induces apoptosis in breast carcinoma cells
2000 • 67 citations
Centrin in the photoreceptor cells of mammalian retinae
1995 • 63 citations
Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors
1999 • 59 citations
Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product
2002 • 54 citations
Peptide aptamers: powerful new tools for molecular medicine
2000 • 52 citations
Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV‐16 E7 oncoprotein
2001 • 48 citations
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
2001 • 46 citations
Peptides as New Inhibitors of HIV-1 Reverse Transcriptase and Integrase
2003 • 26 citations
Peptide aptamers: new tools to study protein interactions
2001 • 17 citations